Oncosil Medical Debt 2024

Oncosil Medical Aktienanalyse

What does Oncosil Medical do?

Oncosil Medical Ltd is an Australian company specializing in the development and distribution of innovative medical products for the treatment of cancer. The company was founded in 2005 and is based in Sydney. The business model of Oncosil Medical is based on research, development, and marketing of products specifically tailored to the needs of cancer patients. The company focuses on developing medical products that aim to improve the effectiveness of radiation therapy and chemotherapy. The core product of Oncosil Medical is the Oncosil implant. It is a small, implantable catheter containing tiny radioactive silicon particles. The implant is directly inserted into the tumor and releases controlled radiation to specifically destroy the tumor. The Oncosil implant is a promising and innovative new treatment option for many cancer patients. It is particularly suitable for patients with locally advanced pancreatic cancer, which is especially difficult to treat. Studies have shown that the Oncosil implant can significantly improve patients' survival rate. Oncosil Medical also provides other products, such as the Microsil transponder. The Microsil transponder is a small implant used in radiation therapy to make the irradiation of the tumor more effective. The transponder is directly inserted into the tumor, allowing medical professionals to precisely target the radiation to the tumor. In addition to developing and marketing innovative medical products, Oncosil Medical also has a research and development department. The company is constantly searching for new cancer treatment methods and works closely with scientists and researchers to develop new technologies. Oncosil Medical operates in several areas. In addition to developing and marketing medical products, the company also offers a training and education program for doctors and medical personnel. The program ensures that all users of Oncosil Medical's products have the necessary skills and knowledge to use the products safely and effectively. The company also has its own regulatory affairs department, which deals with the application for approvals for new products and procedures. This department works closely with authorities and regulatory agencies to ensure that all products from Oncosil Medical comply with applicable regulations and standards. Overall, Oncosil Medical is an innovative and emerging company specializing in the development and marketing of medical products for cancer treatment. With its highly skilled team of scientists, doctors, and qualified professionals, the company stays up to date with the latest research and technology to ensure that its products are always state-of-the-art and provide customers with the best possible treatment option. Oncosil Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Oncosil Medical's Debt Structure

Oncosil Medical's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Oncosil Medical's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Oncosil Medical’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Oncosil Medical’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Oncosil Medical stock

What is the debt of Oncosil Medical this year?

Oncosil Medical has a debt level of -9.11 AUD this year.

What was the debt of Oncosil Medical compared to the previous year?

The debt of Oncosil Medical has increased by -16.14% compared to the previous year dropped.

What are the consequences of high debt for investors in Oncosil Medical?

High debt can pose a risk for investors of Oncosil Medical, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Oncosil Medical?

Low debt means that Oncosil Medical has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Oncosil Medical affect the company?

An increase in debt of Oncosil Medical can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Oncosil Medical affect the company?

A reduction in debt of Oncosil Medical can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Oncosil Medical?

Some factors that can influence the debt of Oncosil Medical include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Oncosil Medical so important for investors?

The debts of Oncosil Medical are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Oncosil Medical take to change the debt?

To change the debt, Oncosil Medical can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Oncosil Medical pay?

Over the past 12 months, Oncosil Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oncosil Medical is expected to pay a dividend of 0 AUD.

What is the dividend yield of Oncosil Medical?

The current dividend yield of Oncosil Medical is .

When does Oncosil Medical pay dividends?

Oncosil Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oncosil Medical?

Oncosil Medical paid dividends every year for the past 0 years.

What is the dividend of Oncosil Medical?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oncosil Medical located?

Oncosil Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oncosil Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oncosil Medical from 9/13/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Oncosil Medical pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of Oncosil Medical in the year 2023?

In the year 2023, Oncosil Medical distributed 0 AUD as dividends.

In which currency does Oncosil Medical pay out the dividend?

The dividends of Oncosil Medical are distributed in AUD.